Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Molecular Cytogenetics|January 19, 2018
Overexpression of the proneural transcription factor ASCL1 in chronic lymphocytic leukemia with a t(12;14)(q23.2;q32.3)Theodora Malli, Melanie Rammer, Sabrina Haslinger, et al.
Diagnostic Pathology|March 16, 2011
Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemiaJohanna M Kralik, Wolfgang Kranewitter, Hans Boesmueller, et al.
Hematological Oncology|August 7, 2020
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1Sonja Heibl, Veronika Buxhofer-Ausch, Stefan Schmidt, et al.
American Journal of Medical Genetics. Part A|September 25, 2014
Disruption of the ARID1B and ADAMTS6 loci due to a t(5;6)(q12.3;q25.3) in a patient with developmental delayTheodora Malli, Hans-Christoph Duba, Martin Erdel, et al.
Data in Brief|March 4, 2022
Data of 'Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage'Patrick Kirchweger, Alexander Kupferthaler, Jonathan Burghofer, et al.
Neuro-Oncology|February 15, 2015
Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosisSabine Spiegl-Kreinecker, Daniela Lötsch, Bahil Ghanim, et al.
Virchows Archiv : an International Journal of Pathology|June 30, 2011
Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapyHans Bösmüller, Sophie Haitchi-Petnehazy, Gerald Webersinke, et al.
Neuro-Oncology|July 17, 2018
TERT promoter mutations are associated with poor prognosis and cell immortalization in meningiomaSabine Spiegl-Kreinecker, Daniela Lötsch, Katharina Neumayer, et al.
Cancers|October 16, 2024
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center AnalysisSigrid Machherndl-Spandl, Sarah Hannouf, Alexander Nikoloudis, et al.
Genes, Chromosomes & Cancer|September 23, 2015
Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndromeTheodora Malli, Veronika Buxhofer-Ausch, Melanie Rammer, et al.
Pageof 5